Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CD-133-targeted oncolytic adenovirus therapy shows promising preclinical results

July 3, 2015

First-in-human results presented for LY-3023414

July 3, 2015

Prolong's novel ANF compound for hematopoiesis deficiencies

July 2, 2015

GlaxoSmithKline presents phase Ib results of GSK-2256098

July 2, 2015

KBP-089: an antiobesity dual amylin and calcitonin receptor agonist

July 2, 2015

Preclinical data of SIRM antibody support further development

July 2, 2015

Scientists disclose phase I results for PepCan

July 2, 2015

Combination of durvalumab with dabrafenib and/or trametinib

July 1, 2015

New biomarker identified for anti-EGFR therapy prognosis

July 1, 2015

McMaster University develops a novel model of cancer-induced depression

July 1, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...